Innovative oleogel systems using ethylcellulose and crystalline gelators offer silicone-free oil thickening for personal care products, enhancing performance traits like oil binding and rheological behavior.
This solution presents a cutting-edge approach to developing silicone-free oil thickeners for personal care products using oleogels. By leveraging multi-component oleogel systems, the research focuses on combining ethylcellulose (EC) with crystalline gelators such as monoglycerides, fatty acids, and natural waxes. This combination enhances the structuring power and functional traits of oils, offering improvements in oil binding, brittleness reduction, and rheological behavior modification. These oleogels provide significant formulation flexibility, allowing the creation of tailored personal care products without the use of silicones.
Key features include:
The oleogels are prepared through thermal dissolution and static solidification, and their performance is characterized by large deformation analysis, oil binding tests, and rheological assessments.
This technology is at Technology Readiness Level 3, indicating that it is in the early stages of experimental proof of concept. Future validation plans include evaluating EC-crystalline gelator combinations, analyzing additives, and employing response surface methodology to optimize formulations.
UC Davis is a comprehensive public research university in Northern California, combining a land-grant heritage with an integrated academic health system and a veterinary teaching hospital. Industry engages through co-located clinical and translational facilities in Sacramento, a campus-adjacent research park, pilot-scale food and bioprocessing facilities, and a statewide extension network for field-to-market deployment. Proximity to the Bay Area and California's Central Valley enables rapid collaboration with startups and established enterprises, while corporate relations staff streamline access to faculty, talent, and core labs. Research is supported by competitive federal funding from agencies such as NIH, NSF, USDA, and DOE. A dedicated technology transfer office and venture support programs provide IP management, licensing, and startup formation pathways for industry partnerships.